FDA approves Rasonque for advanced pancreatic cancer
By The BriefBrief
The U.S. Food and Drug Administration announced approval of Rasonque, a new treatment option for people with pancreatic cancer. The approval was made public on Wednesday.
WHO:U.S. Food and Drug Administration
WHAT:Approved Rasonque as a new treatment option for people with pancreatic cancer
